These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 23182043

  • 1. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
    Deveci A, Coban AY, Acicbe O, Tanyel E, Yaman G, Durupinar B.
    J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043
    [Abstract] [Full Text] [Related]

  • 2. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H, Kus H, Arslan U, Tuncer I.
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [Abstract] [Full Text] [Related]

  • 3. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
    Dong X, Chen F, Zhang Y, Liu H, Liu Y, Ma L.
    J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method.
    Thamlikitkul V, Tiengrim S.
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S1-6. PubMed ID: 24772574
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B, Bai Y, Liu Y, Di X, Zhang X, Wang R, Wang J.
    J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
    [Abstract] [Full Text] [Related]

  • 12. [Combined drug sensitivity test of 50 strains of extensively drug-resistant Acinetobacter baumannii].
    Lu Y, Zhang Y, Zhou H, Yu F, Sun S, Rui Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Nov; 34(11):1697-701. PubMed ID: 25413078
    [Abstract] [Full Text] [Related]

  • 13. A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii.
    Marie MA, Krishnappa LG, Alzahrani AJ, Mubaraki MA, Alyousef AA.
    Bosn J Basic Med Sci; 2015 Oct 14; 15(4):24-9. PubMed ID: 26614848
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y, Telli M, Altunçekiç Yıldırım A, Çalgın MK.
    Mikrobiyol Bul; 2016 Jul 14; 50(3):460-5. PubMed ID: 27525401
    [Abstract] [Full Text] [Related]

  • 15. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S, Kim MC, Park SJ, Kim HS, Sung H, Kim MN, Kim SH, Lee SO, Choi SH, Woo JH, Kim YS, Chong YP.
    Antimicrob Agents Chemother; 2016 Nov 14; 60(11):6774-6779. PubMed ID: 27600048
    [Abstract] [Full Text] [Related]

  • 16. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
    Ozseven AG, Sesli Çetin E, Ozseven L.
    Mikrobiyol Bul; 2012 Jul 14; 46(3):410-20. PubMed ID: 22951653
    [Abstract] [Full Text] [Related]

  • 17. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar 14; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 18. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
    Wang YC, Kuo SC, Yang YS, Lee YT, Chiu CH, Chuang MF, Lin JC, Chang FY, Chen TL.
    Antimicrob Agents Chemother; 2016 Aug 14; 60(8):4670-6. PubMed ID: 27216052
    [Abstract] [Full Text] [Related]

  • 19. In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii.
    Kiffer CR, Sampaio JL, Sinto S, Oplustil CP, Koga PC, Arruda AC, Turner PJ, Mendes C.
    Diagn Microbiol Infect Dis; 2005 Aug 14; 52(4):317-22. PubMed ID: 15936166
    [Abstract] [Full Text] [Related]

  • 20. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
    Fan B, Guan J, Wang X, Cong Y.
    PLoS One; 2016 Aug 14; 11(6):e0157757. PubMed ID: 27315107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.